Clinical Trial Update: Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study of milciclib in unresectable/metastatic hepatocellular carcinoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• milciclib (milciclib)

Snippet

Sponsor: Tiziana Life Sciences LTD | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED